Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Call Volonte today to schedule your FREE low T screening, and follow us on Facebook.
Neither BPC-157 nor TB-500 is an approved therapeutic good in Australia, and neither peptide is registered with the Therapeutic Goods Administration (TGA)
Oral KPV may be prescribed separately starting at $99
certificate of analysis available on request Research Applications Suitable Laboratory Uses for the Wolverine Stack Dual-phase musculoskeletal tissue repair pathway studies vascular/ECM phase (BPC-157) and cell migration/cytoskeletal phase (TB-500) Tendon, ligament, and muscle healing pathway research in pre-clinical models Angiogenesis and vascular network organisation studies VEGF, VEGFR2, ERK1/2 signalling Fibroblast migration, proliferation, and ECM stabilisation assays in vitro Stem and progenitor cell mobilisation and differentiation studies Anti-inflammatory cytokine pathway investigations TNF-, IL-6 modulation Collagen synthesis, fibre alignment, and tissue organisation quality research Monotherapy vs
Capsule form is also frequently studied in comparison to injectable forms to evaluate systemic vs
US$ 21.81
US$ 21.64
US$ 28.58
US$ 22.51
US$ 20.89
US$ 26.98
US$ 27.38
US$ 29.74
